中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2011年
14期
977-979
,共3页
马剑锋%黄志莲%李军%胡社军%连庆泉
馬劍鋒%黃誌蓮%李軍%鬍社軍%連慶泉
마검봉%황지련%리군%호사군%련경천
痛觉过敏%镇痛药%阿片类,瑞芬太尼%影响因素
痛覺過敏%鎮痛藥%阿片類,瑞芬太尼%影響因素
통각과민%진통약%아편류,서분태니%영향인소
Hyperalgesia%Analgesics,opioid%Remifentanil%Influence factor
目的 观察瑞芬太尼引起术后痛觉过敏的发生情况并筛选影响因素.方法 选择2008年6-12月温州医学院附属第二医院术中使用瑞芬太尼和手术切口<4 cm的全麻患者共1620例,分别在麻醉恢复室(PACU)、术后4 h及24 h记录痛觉过敏的发生情况,应用非条件Logistic回归模型分析与痛觉过敏可能有关的6个因素,即年龄、性别、麻醉维持方式、手术时间、手术部位和瑞芬太尼用量.结果 1620例患者共发生痛觉过敏261例(16.1%).年龄<16岁的痛觉过敏发生率为25.9%,≥16岁为15.6%;男性痛觉过敏发生率为20.8%,女性为13.0%;手术时间>2 h痛觉过敏发生率为32.7%,≤2 h为9.9%;瑞芬太尼用量>30μg/kg痛觉过敏发生率为41.8%,≤30 μg/kg为4.8%,不同年龄、性别、手术时间及瑞芬太尼用量间比较,差异均有统计学意义(均P<0.05).痛觉过敏各标准中肢体保护性动作存在及触、冷诱发痛两项发生率最高(39.0%,34.5%).Logistic回归分析结果显示,年龄<16岁、男性、手术时间>2 h和瑞芬太尼用量>30 μg/kg与痛觉过敏的发生存在相关(均P<0.05).结论 年龄<16岁、手术时间较长和瑞芬太尼用量偏多会增加痛觉过敏的发生,麻醉方法和手术部位不会影响痛觉过敏的发生.
目的 觀察瑞芬太尼引起術後痛覺過敏的髮生情況併篩選影響因素.方法 選擇2008年6-12月溫州醫學院附屬第二醫院術中使用瑞芬太尼和手術切口<4 cm的全痳患者共1620例,分彆在痳醉恢複室(PACU)、術後4 h及24 h記錄痛覺過敏的髮生情況,應用非條件Logistic迴歸模型分析與痛覺過敏可能有關的6箇因素,即年齡、性彆、痳醉維持方式、手術時間、手術部位和瑞芬太尼用量.結果 1620例患者共髮生痛覺過敏261例(16.1%).年齡<16歲的痛覺過敏髮生率為25.9%,≥16歲為15.6%;男性痛覺過敏髮生率為20.8%,女性為13.0%;手術時間>2 h痛覺過敏髮生率為32.7%,≤2 h為9.9%;瑞芬太尼用量>30μg/kg痛覺過敏髮生率為41.8%,≤30 μg/kg為4.8%,不同年齡、性彆、手術時間及瑞芬太尼用量間比較,差異均有統計學意義(均P<0.05).痛覺過敏各標準中肢體保護性動作存在及觸、冷誘髮痛兩項髮生率最高(39.0%,34.5%).Logistic迴歸分析結果顯示,年齡<16歲、男性、手術時間>2 h和瑞芬太尼用量>30 μg/kg與痛覺過敏的髮生存在相關(均P<0.05).結論 年齡<16歲、手術時間較長和瑞芬太尼用量偏多會增加痛覺過敏的髮生,痳醉方法和手術部位不會影響痛覺過敏的髮生.
목적 관찰서분태니인기술후통각과민적발생정황병사선영향인소.방법 선택2008년6-12월온주의학원부속제이의원술중사용서분태니화수술절구<4 cm적전마환자공1620례,분별재마취회복실(PACU)、술후4 h급24 h기록통각과민적발생정황,응용비조건Logistic회귀모형분석여통각과민가능유관적6개인소,즉년령、성별、마취유지방식、수술시간、수술부위화서분태니용량.결과 1620례환자공발생통각과민261례(16.1%).년령<16세적통각과민발생솔위25.9%,≥16세위15.6%;남성통각과민발생솔위20.8%,녀성위13.0%;수술시간>2 h통각과민발생솔위32.7%,≤2 h위9.9%;서분태니용량>30μg/kg통각과민발생솔위41.8%,≤30 μg/kg위4.8%,불동년령、성별、수술시간급서분태니용량간비교,차이균유통계학의의(균P<0.05).통각과민각표준중지체보호성동작존재급촉、랭유발통량항발생솔최고(39.0%,34.5%).Logistic회귀분석결과현시,년령<16세、남성、수술시간>2 h화서분태니용량>30 μg/kg여통각과민적발생존재상관(균P<0.05).결론 년령<16세、수술시간교장화서분태니용량편다회증가통각과민적발생,마취방법화수술부위불회영향통각과민적발생.
Objective To investigate the incidence of remifentanil-induced hyperalgesia and screen for the relevant influencing factors in the post-operative patients. Methods A total of 1620 patients from June 2008 to December 2008 in our hospital undergoing general anesthesia with remifentanil and whose length of operative incision was less than 4 cm were enrolled . The incidence of postoperative hyperalgesia was investigated and recorded at the timepoints of staying at post-anesthesia care unit ( PACU ), 4 h and 24 h postoperation respectively. The unconditional statistical analysis of Logistic regression was used to explore such possible influencing factors as age, gender, methods of general anesthesia, operative duration,operative sites and remifentanil dose. Results The incidence of postoperative remifentanil-induced hyperalgesia was 16.1% (n = 261 ). The incidence of postoperative hyperalgesia was significantly increased in patients < 16 yrs (25.9%) vs ≥ 16 yrs ( 15.6% ) (P < 0.05), males vs females (20.8% vs 13.0%,P<0.01), operative duration >2 h (32.7%) vs ≤ 2 h (9.9%) (P<0.01) and remifentanil dose >30 μg/kg (41.8%) vs ≤30 μg/kg (4.8%) (P <0.01 ). And the incidence of limb protective action,touch and cold-induced allodynia were the two highest indicators (39.0%, 34.5% ). Analysis of Logistic regression showed that ages under 16 years old, operative duration >2 h and remifentanil dose >30 μg/kg were relevant with hyperalgesia (all P < 0.05 ). Conclusion Ages under 16 years old, operative duration and remifentanil dose are the risk factors for postoperative remifentanil-induced hyperalgesia. Neither methods of general anesthesia nor operative sites has any effect on the occurrence of hyperalgesia.